
Robert J. Grun
Examiner (ID: 521, Phone: (571)270-5521 , Office: P/1744 )
| Most Active Art Unit | 1744 |
| Art Unit(s) | 4111, 1791, 1744 |
| Total Applications | 931 |
| Issued Applications | 642 |
| Pending Applications | 3 |
| Abandoned Applications | 289 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9827932
[patent_doc_number] => 08937160
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-20
[patent_title] => 'Pharmaceutical composition for treating and/or preventing cancer'
[patent_app_type] => utility
[patent_app_number] => 13/577212
[patent_app_country] => US
[patent_app_date] => 2011-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22928
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13577212
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/577212 | Pharmaceutical composition for treating and/or preventing cancer | Feb 3, 2011 | Issued |
Array
(
[id] => 7587238
[patent_doc_number] => 20110281748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'DRUG SELECTION FOR GASTRIC CANCER THERAPY USING ANTIBODY-BASED ARRAYS'
[patent_app_type] => utility
[patent_app_number] => 13/014674
[patent_app_country] => US
[patent_app_date] => 2011-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 58293
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281748.pdf
[firstpage_image] =>[orig_patent_app_number] => 13014674
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/014674 | Drug selection for gastric cancer therapy using antibody-based arrays | Jan 25, 2011 | Issued |
Array
(
[id] => 7587238
[patent_doc_number] => 20110281748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'DRUG SELECTION FOR GASTRIC CANCER THERAPY USING ANTIBODY-BASED ARRAYS'
[patent_app_type] => utility
[patent_app_number] => 13/014674
[patent_app_country] => US
[patent_app_date] => 2011-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 58293
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281748.pdf
[firstpage_image] =>[orig_patent_app_number] => 13014674
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/014674 | Drug selection for gastric cancer therapy using antibody-based arrays | Jan 25, 2011 | Issued |
Array
(
[id] => 8171287
[patent_doc_number] => 20120107303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'SYNERGISTIC TREATMENT OF CANCER USING IMMUNOMERS IN CONJUNCTION WITH CHEMOTHERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/006860
[patent_app_country] => US
[patent_app_date] => 2011-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 17201
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20120107303.pdf
[firstpage_image] =>[orig_patent_app_number] => 13006860
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/006860 | SYNERGISTIC TREATMENT OF CANCER USING IMMUNOMERS IN CONJUNCTION WITH CHEMOTHERAPEUTIC AGENTS | Jan 13, 2011 | Abandoned |
Array
(
[id] => 8670671
[patent_doc_number] => 20130045209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'WNT-Binding Agents and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/521331
[patent_app_country] => US
[patent_app_date] => 2011-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 24484
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13521331
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/521331 | WNT-Binding Agents and Uses Thereof | Jan 11, 2011 | Abandoned |
Array
(
[id] => 8685264
[patent_doc_number] => 20130053549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'Multivalent Antibodies'
[patent_app_type] => utility
[patent_app_number] => 13/521818
[patent_app_country] => US
[patent_app_date] => 2011-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11234
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13521818
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/521818 | Multivalent Antibodies | Jan 11, 2011 | Abandoned |
Array
(
[id] => 8683910
[patent_doc_number] => 20130052194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'ANTI-PROSTATE CANCER ANTIBODIES AND METHODS OF DETECTION AND TREATMENT OF PROSTATE CANCER USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/516305
[patent_app_country] => US
[patent_app_date] => 2010-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13192
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516305
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/516305 | ANTI-PROSTATE CANCER ANTIBODIES AND METHODS OF DETECTION AND TREATMENT OF PROSTATE CANCER USING THE SAME | Dec 15, 2010 | Abandoned |
Array
(
[id] => 6214756
[patent_doc_number] => 20110137016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR'
[patent_app_type] => utility
[patent_app_number] => 12/956282
[patent_app_country] => US
[patent_app_date] => 2010-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 68318
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20110137016.pdf
[firstpage_image] =>[orig_patent_app_number] => 12956282
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/956282 | Compositions and methods for the diagnosis and treatment of tumor | Nov 29, 2010 | Issued |
Array
(
[id] => 8464647
[patent_doc_number] => 20120269814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'ANTI-C MPL ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 13/508973
[patent_app_country] => US
[patent_app_date] => 2010-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 41522
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508973
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/508973 | ANTI-C MPL ANTIBODIES | Nov 9, 2010 | Abandoned |
Array
(
[id] => 8522666
[patent_doc_number] => 20120322074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'Prostate Tumor Markers and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/503396
[patent_app_country] => US
[patent_app_date] => 2010-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8287
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503396
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/503396 | Prostate tumor markers and methods of use thereof | Oct 25, 2010 | Issued |
Array
(
[id] => 8612234
[patent_doc_number] => 20130017546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'Breast Tumor Markers and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/503430
[patent_app_country] => US
[patent_app_date] => 2010-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 13841
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503430
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/503430 | Breast Tumor Markers and Methods of Use Thereof | Oct 25, 2010 | Abandoned |
Array
(
[id] => 8586134
[patent_doc_number] => 20130004955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-03
[patent_title] => 'Ovary Tumor Markers and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/503417
[patent_app_country] => US
[patent_app_date] => 2010-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 14010
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503417
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/503417 | Ovary tumor markers and methods of use thereof | Oct 25, 2010 | Issued |
Array
(
[id] => 8617671
[patent_doc_number] => 20130022983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-24
[patent_title] => 'Colon and Rectal Tumor Markers and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/503403
[patent_app_country] => US
[patent_app_date] => 2010-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 15706
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503403
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/503403 | Colon and Rectal Tumor Markers and Methods of Use Thereof | Oct 25, 2010 | Abandoned |
Array
(
[id] => 9777405
[patent_doc_number] => 08852604
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-07
[patent_title] => 'Multiepitope vaccine for Her2/neu-associated cancers'
[patent_app_type] => utility
[patent_app_number] => 13/389419
[patent_app_country] => US
[patent_app_date] => 2010-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15128
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389419
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/389419 | Multiepitope vaccine for Her2/neu-associated cancers | Aug 17, 2010 | Issued |
Array
(
[id] => 11520572
[patent_doc_number] => 09603954
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-28
[patent_title] => 'Methods for generating radioimmunoconjugates'
[patent_app_type] => utility
[patent_app_number] => 13/386316
[patent_app_country] => US
[patent_app_date] => 2010-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15388
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386316
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/386316 | Methods for generating radioimmunoconjugates | Jul 21, 2010 | Issued |
Array
(
[id] => 5954790
[patent_doc_number] => 20110034675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'Ilt3 Binding Molecules And Uses Therefor'
[patent_app_type] => utility
[patent_app_number] => 12/831156
[patent_app_country] => US
[patent_app_date] => 2010-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 32748
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034675.pdf
[firstpage_image] =>[orig_patent_app_number] => 12831156
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/831156 | Ilt3 Binding Molecules And Uses Therefor | Jul 5, 2010 | Abandoned |
Array
(
[id] => 8733073
[patent_doc_number] => 20130078642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-28
[patent_title] => 'BIOMARKERS FOR LUNG NEUROENDOCRINE TUMORS'
[patent_app_type] => utility
[patent_app_number] => 13/701420
[patent_app_country] => US
[patent_app_date] => 2010-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5805
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701420
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/701420 | BIOMARKERS FOR LUNG NEUROENDOCRINE TUMORS | Jun 2, 2010 | Abandoned |
Array
(
[id] => 10587723
[patent_doc_number] => 09309325
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Antibodies and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/319036
[patent_app_country] => US
[patent_app_date] => 2010-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 19
[patent_no_of_words] => 36664
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319036
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/319036 | Antibodies and methods of use thereof | May 3, 2010 | Issued |
Array
(
[id] => 10141104
[patent_doc_number] => 09173891
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-03
[patent_title] => 'Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog'
[patent_app_type] => utility
[patent_app_number] => 13/265309
[patent_app_country] => US
[patent_app_date] => 2010-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 14091
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13265309
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/265309 | Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog | Apr 19, 2010 | Issued |
Array
(
[id] => 9435099
[patent_doc_number] => 20140113006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-24
[patent_title] => 'METHODS OF DETERMINING WHETHER THE WNT SIGNALING PATHWAY IS UPREGULATED IN A TUMOR'
[patent_app_type] => utility
[patent_app_number] => 13/825155
[patent_app_country] => US
[patent_app_date] => 2010-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 17495
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825155
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/825155 | METHODS OF DETERMINING WHETHER THE WNT SIGNALING PATHWAY IS UPREGULATED IN A TUMOR | Apr 18, 2010 | Abandoned |